MedTrace Logo

Myopia Control With the Multi-segment Lens

NCT02206217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2020-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the Multiple-Segment (MS) spectacle lens can slow myopia progression in Hong Kong schoolchildren.

MS lens is also called Defocus Incorporated Multiple Segments (DIMS) spectacle lens

Conditions

  • Myopia

Interventions

DEVICE

Multiple-Segment spectacle lens

A multifocal spectacle lens that corrects distance refraction and provides myopic defocus images simultaneously. The myopic defocus aims at slowing down myopia progression.

Sponsors & Collaborators

  • HOYA Corporation (Tokyo, Japan)

    collaborator UNKNOWN

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Carly SY Lam, PhD · The Hong Kong Polytechnic University

  • Chi ho To, PhD · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • China
  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02206217 on ClinicalTrials.gov